6th annual Regenerative Medicine Essentials Course Set for June 10 - 14.
May 13, 2019 10:01 ET
|
Regenerative Medicine Foundation
Winston-Salem, NC, May 13, 2019 (GLOBE NEWSWIRE) -- WINSTON-SALEM, NC – The sixth annual Regenerative Medicine Essentials Course will be held June 10 - 14 in downtown Winston-Salem. The course is...
Hemostemix Announces Convertible Debenture Financing
April 15, 2019 08:30 ET
|
Hemostemix Inc.
NOT FOR DISTRIBTUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, April 15, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX...
Leapsmag and the Regenerative Medicine Foundation launch video series “The Future Is Now: The Revolutionary Power of Stem Cell Research"
April 03, 2019 15:01 ET
|
Regenerative Medicine Foundation
Los Angeles, CA, April 03, 2019 (GLOBE NEWSWIRE) -- Leapsmag, the online magazine showcasing groundbreaking advances in the life sciences, and the Regenerative Medicine Foundation (RMF) have...
Transplant Matches Identified by Ultra-High-Resolution HLA Typing Associated with Higher Patient Survival Rates
April 02, 2019 07:30 ET
|
Pacific Biosciences of California, Inc.
In a retrospective study, Anthony Nolan Research Institute found SMRT® Sequencing identified superior HLA matches, which are critical in determining successful transplant outcomes MENLO PARK, Calif.,...
Hemostemix Announces Appointment of Experienced Chief Medical Officer & President
April 01, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, April 01, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that Dr. Alan J. Jacobs, M.S.EE, M.D,...
Cynata Receives Favourable Advice from UK MHRA on CLI Clinical Trial
March 12, 2019 09:03 ET
|
Cynata Therapeutics Limited
MELBOURNE, Australia, March 12, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that...
Amniotic Stem Cell Co-culture System Significantly Promotes Wound Healing
February 28, 2019 11:59 ET
|
Merakris Therapeutics
Merakris Therapeutics’ Lead Scientist, Sam Fagg MSc, PhD, Presents the Research Triangle Park-based Company’s Amniotic Stem Cell Co-culture RALEIGH, NC, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via...
Hemostemix Announces UC Davis Health Added as a Trial Site for Phase II Clinical Trial
February 25, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB:HMTXF) is pleased to announce that it has received all approvals from UC...
Hemostemix Announces Submission of Orphan Drug Designation Application to the FDA
February 04, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) a biotechnology company focused on developing and commercializing...
The 2019 Co-located Phacilitate Leaders World & World Stem Cell Summit in Miami Solidified Regenerative Medicine as the Future of Healthcare
January 25, 2019 17:58 ET
|
Regenerative Medicine Foundation & Phacilitate Leaders World
Miami, FL, Jan. 25, 2019 (GLOBE NEWSWIRE) -- The international regenerative medicine community concluded a week of sharing breakthroughs, facing challenges and developing collaborations at the 2019...